Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2017
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
Alfredo Carrato, Albert Abad, Bartomeu Massuti, et al.
Cancer
|
February 7, 2023
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Do-Youn Oh, Alain Algazi, Jaume Capdevila, et al.
Nature Cancer
|
February 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial
Aurelien Marabelle, David M O'Malley, Andrew E Hendifar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2022
Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study
Michele Maio, Mayur M Amonkar, Josephine M Norquist, et al.
Cancers
|
August 7, 2021
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, et al.
Plos One
|
October 25, 2016
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain
Virginia Lope, Nerea Fernández de Larrea, Beatriz Pérez-Gómez, et al.
Cancers
|
September 28, 2021
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
Pilar García-Alfonso, Andrés Muñoz, Jerónimo Jiménez-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
Journal of Geriatric Oncology
|
December 16, 2017
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
Laura Visa, Paula Jiménez-Fonseca, Elena Asensio Martínez, et al.
Future Oncology (London, England)
|
February 16, 2021
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study
Federico Longo, Mónica Jorge, Ricardo Yaya, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2017
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
Alfredo Carrato, Albert Abad, Bartomeu Massuti, et al.
Cancer
|
February 7, 2023
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Do-Youn Oh, Alain Algazi, Jaume Capdevila, et al.
Nature Cancer
|
February 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial
Aurelien Marabelle, David M O'Malley, Andrew E Hendifar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2022
Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study
Michele Maio, Mayur M Amonkar, Josephine M Norquist, et al.
Cancers
|
August 7, 2021
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, et al.
Plos One
|
October 25, 2016
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain
Virginia Lope, Nerea Fernández de Larrea, Beatriz Pérez-Gómez, et al.
Cancers
|
September 28, 2021
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
Pilar García-Alfonso, Andrés Muñoz, Jerónimo Jiménez-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study
Maria Alsina, Guillermo Villacampa, Carlos de Andrea, et al.
Journal of Geriatric Oncology
|
December 16, 2017
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
Laura Visa, Paula Jiménez-Fonseca, Elena Asensio Martínez, et al.
Future Oncology (London, England)
|
February 16, 2021
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study
Federico Longo, Mónica Jorge, Ricardo Yaya, et al.
Page
of 7